Log in to save to my catalogue

75 Generalizability of potential biomarkers of response to CTLA-4 and PD-1 blockade therapy in cance...

75 Generalizability of potential biomarkers of response to CTLA-4 and PD-1 blockade therapy in cance...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2553000905

75 Generalizability of potential biomarkers of response to CTLA-4 and PD-1 blockade therapy in cancer

About this item

Full title

75 Generalizability of potential biomarkers of response to CTLA-4 and PD-1 blockade therapy in cancer

Publisher

London: BMJ Publishing Group LTD

Journal title

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A46-A47

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

BackgroundMultiple genomics-based biomarkers of response to immune checkpoint inhibition have been reported or proposed, including tumor mutation/neoantigen frequency, PD-L1 expression, T cell receptor repertoire clonality, interferon gene signature expression, HLA expression, and others.1 Although genomics associations of response have been report...

Alternative Titles

Full title

75 Generalizability of potential biomarkers of response to CTLA-4 and PD-1 blockade therapy in cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2553000905

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2553000905

Other Identifiers

E-ISSN

2051-1426

DOI

10.1136/jitc-2020-SITC2020.0075

How to access this item